Antibiotic Adjuvant 4-Hexylresorcinol Enhances the Efficiency of Antituberculosis Drugs
Bulletin of Experimental Biology and Medicine · 2024
DOI: 10.1007/s10517-024-06048-5 ↗Kurz gefasst
Fachartikel in der Zeitschrift Bulletin of Experimental Biology and Medicine, 2024. Verfasst von Yu A Nikolaev und 7 weiteren Autor:innen. Beteiligte Einrichtung: Federal Research Centre "Fundamentals of Biotechnology", Russian Academy of Sciences, Moscow, Russia. Hauptthemen laut MEDLINE: Hexylresorcinol, Mycobacterium tuberculosis, Tuberculosis. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 9 Literaturangaben.
Abstract (Originalsprache)
We studied the possibility of using 4-hexylresorcinol to increase the efficiency of anti-mycobacterial chemotherapy. In an in vitro experiment, 4-hexylresorcinol increased the efficiency of rifampicin, kanamycin, and isoniazid against Mycobacterium smegmatis by 3-5 times. Experiments in sanitation of BALB/c mice infected with M. smegmatis showed the best efficacy of the isoniazid and 4-hexylresorcinol combination in comparison with isoniazid monotherapy. The growth-inhibiting activity of the combination of antibiotic rifabutin with 4-hexylresorcinol was shown on 6 strains of M. tuberculosis. A 2-fold decrease in the minimum inhibitory concentration of this antibiotic in the presence of half-minimum inhibitory concentration of 4-hexylresorcinol was demonstrated for monoresistant strain M. tuberculosis 5360/42Hr. On the mouse model of experimental tuberculosis caused by M. tuberculosis H37Rv, a 5-fold decrease in lung contamination and more rapid complete cure were achieved in animals treated with the combination of rifabutin and 4-hexylresorcinol in comparison with rifabutin monotherapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Federal Research Centre "Fundamentals of Biotechnology", Russian Academy of Sciences, Moscow, Russia.
- State Research Center for Applied Microbiology and Biotechnology, Federal Service of Consumer Right Surveillance and Human Welfare, Obolensk, Moscow Region, Russia.
- State Research Center for Applied Microbiology and Biotechnology, Federal Service of Consumer Right Surveillance and Human Welfare, Obolensk, Moscow Region, Russia. manzenyuk@obolensk.org.
Zitieren
APA
Nikolaev, Y. A., Mukhina, T. N., Potapov, V. D., Kuznetsov, B. B., El'-Registan, G. I., Firstova, V. V., Shemyakin, I. G., & Manzenyuk, O. Y. (2024). Antibiotic Adjuvant 4-Hexylresorcinol Enhances the Efficiency of Antituberculosis Drugs. Bulletin of Experimental Biology and Medicine. https://doi.org/10.1007/s10517-024-06048-5
Vancouver
Nikolaev YA, Mukhina TN, Potapov VD, Kuznetsov BB, El'-Registan GI, Firstova VV, et al. Antibiotic Adjuvant 4-Hexylresorcinol Enhances the Efficiency of Antituberculosis Drugs. Bulletin of Experimental Biology and Medicine. 2024. doi:10.1007/s10517-024-06048-5
BibTeX
@article{Nikolaev2024,
author = {Nikolaev, Yu A and Mukhina, T N and Potapov, V D and Kuznetsov, B B and El'-Registan, G I and Firstova, V V and Shemyakin, I G and Manzenyuk, O Yu},
title = {Antibiotic Adjuvant 4-Hexylresorcinol Enhances the Efficiency of Antituberculosis Drugs},
journal = {Bulletin of Experimental Biology and Medicine},
year = {2024},
doi = {10.1007/s10517-024-06048-5}
}
EUVIMED